| Analysis at 2/19/2026 | YTD | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Performance | 3.71% | 36.69% | 48.03% | 30.38% |
| Analysis at 2/19/2026 | 1 year | 3 years | 5 years |
|---|---|---|---|
| Volatility | 19.63% | 17.62% | 17.03% |
| Negative volatility | 9.68% | 10.27% | 10.97% |
| Sharpe | 1.43 | 0.57 | 0.29 |
| Sortino | 2.91 | 0.98 | 0.45 |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
| Candriam Eq. L Biotechnology C EUR Hdg | -3.71% | -5.21% | 5.25% | 0.75% | 34.97% | 3.71% | |
| Equity Sector - Healthcare EUR Hedged | 3.58% | -13.01% | 2.60% | -1.34% | 17.19% | -0.40% | |